AIPolyphron announces $20 million seed round for AI-driven biology verification
Quiet Capital led the round, Polyphron says, with participation from Gradient, Haystack, Compound and others. The company also announced a new co-founder joining from Google DeepMind.
TLDR
Polyphron announced $20 million in seed financing to build a system where AI models can test predictions and learn against living human biology. The company argues that progress in generating biological hypotheses, therapeutic candidates and experimental designs is outpacing the ability to test their effects. Its bet is that tissue is the fastest, cheapest and most parallelizable testing substrate that still contains the biology that matters.
Combined views
48.3K
1 Source, first seen 11h ago
Polyphron announces $20 million seed round for AI-driven biology verification
Quiet Capital led the round, Polyphron says, with participation from Gradient, Haystack, Compound and others. The company also announced a new co-founder joining from Google DeepMind.
TLDR
Polyphron announced $20 million in seed financing to build a system where AI models can test predictions and learn against living human biology. The company argues that progress in generating biological hypotheses, therapeutic candidates and experimental designs is outpacing the ability to test their effects. Its bet is that tissue is the fastest, cheapest and most parallelizable testing substrate that still contains the biology that matters.